Skip to main content

Table 2 Clinicopathological features of altered and unaltered patients with LUSC from TCGA

From: Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes

  

Unaltered(n = 59)

Altered(n = 119)

p-value

Sex

   

0.278

Female

19

28

 

Male

40

91

 

Age

   

0.386

< 65

15

40

 

≥ 65

42

78

 

NA

2

1

 

Race

   

0.769

White

41

72

 

Non-white

4

10

 

NA

14

37

 

Smoking_history

   

1.000

Yes

57

116

 

No

2

3

 

Cancer_status

   

0.658

With cancer

10

18

 

Cancer free

49

101

 

Pathologic_stage

   

0.978

I

34

65

 

II

12

27

 

III

12

23

 

IV

1

2

 

NA

0

2

 

T stage

   

0.539

T1

16

21

 

T2

35

80

 

T3

4

10

 

T4

4

8

 

N stage

   

0.521

N0

40

76

 

N1

10

29

 

N2

6

11

 

N3

2

3

 

NX

1

0

 

M stage

   

0.172

M0

53

112

 

M1

1

2

 

MX

4

2

 

NA

1

3

 
  1. Altered, LUSC patients with mutation and/or copy number variation; Unaltered, LUSC patients without mutation and/or copy number variation; LUSC lung squamous cell cancer, TCGA The Cancer Genome Atlas
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us